BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 10946264)

  • 1. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses.
    Belz GT; Stevenson PG; Doherty PC
    J Immunol; 2000 Sep; 165(5):2404-9. PubMed ID: 10946264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection.
    Seaman MS; Wang CR; Forman J
    J Immunol; 2000 Nov; 165(9):5192-201. PubMed ID: 11046052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses.
    Belz GT; Xie W; Doherty PC
    J Immunol; 2001 Apr; 166(7):4627-33. PubMed ID: 11254721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
    Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
    J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection.
    Blattman JN; Sourdive DJ; Murali-Krishna K; Ahmed R; Altman JD
    J Immunol; 2000 Dec; 165(11):6081-90. PubMed ID: 11086040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function.
    Day EB; Charlton KL; La Gruta NL; Doherty PC; Turner SJ
    J Immunol; 2011 Jun; 186(11):6319-28. PubMed ID: 21536802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
    La Gruta NL; Turner SJ; Doherty PC
    J Immunol; 2004 May; 172(9):5553-60. PubMed ID: 15100298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidity of CD8 T cells sharpens immunodominance.
    Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new H-2D(k)-restricted epitope prominent in primary influenza A virus infection.
    Tourdot S; Herath S; Gould KG
    J Gen Virol; 2001 Jul; 82(Pt 7):1749-1755. PubMed ID: 11413387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting.
    Jenkins MR; Webby R; Doherty PC; Turner SJ
    J Immunol; 2006 Sep; 177(5):2917-25. PubMed ID: 16920927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.
    Drake DR; Ream RM; Lawrence CW; Braciale TJ
    J Immunol; 2005 Aug; 175(3):1507-15. PubMed ID: 16034088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.
    Belz GT; Xie W; Altman JD; Doherty PC
    J Virol; 2000 Apr; 74(8):3486-93. PubMed ID: 10729122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF; Green WR
    J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
    Berkhoff EG; Geelhoed-Mieras MM; Verschuren EJ; van Baalen CA; Gruters RA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Clin Exp Immunol; 2007 May; 148(2):296-306. PubMed ID: 17326762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
    Crowe SR; Miller SC; Shenyo RM; Woodland DL
    J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered immunodominance hierarchies of influenza A virus-specific H-2(b)-restricted CD8+ T cells in the absence of terminal deoxynucleotidyl transferase.
    Leon-Ponte M; Kasprzyski T; Mannik LA; Haeryfar SM
    Immunol Invest; 2008; 37(7):714-25. PubMed ID: 18821218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus.
    Chen W; Bennink JR; Morton PA; Yewdell JW
    J Virol; 2002 Oct; 76(20):10332-7. PubMed ID: 12239309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.